{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:42:26Z","timestamp":1776087746756,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-02913-6","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:05:39Z","timestamp":1772769939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipoprotein(a) and large artery atherosclerosis: results from the BIOSIGNAL study"],"prefix":"10.1186","volume":"25","author":[{"given":"Felix","family":"Gross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Sch\u00fctz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Inauen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Pokorny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Wegener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas R.","family":"Luft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Spanaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold von","family":"Eckardstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Jean","family":"Touboul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira","family":"Katan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"issue":"39","key":"2913_CR1","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","volume":"43","author":"F Kronenberg","year":"2022","unstructured":"Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925\u201346.","journal-title":"Eur Heart J"},{"issue":"3","key":"2913_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s40256-020-00437-7","volume":"21","author":"N Eraikhuemen","year":"2021","unstructured":"Eraikhuemen N, Lazaridis D, Dutton MT. Emerging pharmacotherapy to reduce elevated lipoprotein(a) plasma levels. Am J Cardiovasc Drugs. 2021;21(3):255\u201365.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"6","key":"2913_CR3","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1161\/STROKEAHA.106.480657","volume":"38","author":"B Smolders","year":"2007","unstructured":"Smolders B, Lemmens R, Thijs V. Lipoprotein (a) and stroke: a meta-analysis of observational studies. Stroke. 2007;38(6):1959\u201366.","journal-title":"Stroke"},{"key":"2913_CR4","doi-asserted-by":"crossref","unstructured":"Xu J, Hao X, Zhan R, Jiang X, Jin A, Xue J, et al. Effect of Lipoprotein(a) on stroke recurrence attenuates at low LDL-C (Low-Density Lipoprotein) and inflammation levels. Stroke. 2022;(July):1\u20138.","DOI":"10.1161\/STROKEAHA.121.034924"},{"issue":"22","key":"2913_CR5","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/eurheartj\/ehab081","volume":"42","author":"M Arnold","year":"2021","unstructured":"Arnold M, Schweizer J, Nakas CT, Sch\u00fctz V, Westphal LP, Inauen C, et al. Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: Results from the BIOSIGNAL study. Eur Heart J. 2021;42(22):2186\u201396.","journal-title":"Eur Heart J"},{"issue":"7","key":"2913_CR6","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1161\/ATVBAHA.112.251306","volume":"32","author":"JD Spence","year":"2012","unstructured":"Spence JD, Koschinsky M. Mechanisms of lipoprotein(a) pathogenicity: prothrombotic, proatherosclerotic, or both? Arterioscler Thromb Vasc Biol. 2012;32(7):1550\u20131.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"2913_CR7","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2471\/BLT.07.045120","volume":"85","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbrouckef JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007;85(11):867\u201372.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"2913_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"BB Love","year":"1993","unstructured":"Love BB, Bendixen BH. Classification of subtype of acute ischemic stroke definitions for use in a multicenter clinical trial. Stroke. 1993;24(1):35\u201341.","journal-title":"Stroke"},{"issue":"5","key":"2913_CR9","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/ana.20617","volume":"58","author":"H Ay","year":"2005","unstructured":"Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol. 2005;58(5):688\u201397.","journal-title":"Ann Neurol"},{"issue":"2","key":"2913_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1148\/radiol.2292030516","volume":"229","author":"EG Grant","year":"2003","unstructured":"Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid artery stenosis: gray-scale and Doppler US Diagnosis - society of radiologists in ultrasound consensus conference. Radiology. 2003;229(2):340\u20136.","journal-title":"Radiology"},{"issue":"3","key":"2913_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/STROKEAHA.111.636084","volume":"43","author":"GM Von Reutern","year":"2012","unstructured":"Von Reutern GM, Goertler MW, Bornstein NM, Sette MD, Evans DH, Hetzel A, et al. Grading carotid stenosis using ultrasonic methods. Stroke. 2012;43(3):916\u201321.","journal-title":"Stroke"},{"issue":"10","key":"2913_CR12","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1161\/STROKEAHA.109.555169","volume":"40","author":"M Nedelmann","year":"2009","unstructured":"Nedelmann M, Stolz E, Gerriets T, Baumgartner RW, Malferrari G, Seidel G, et al. Consensus recommendations for transcranial color-coded duplex sonography for the assessment of intracranial arteries in clinical trials on acute stroke. Stroke. 2009;40(10):3238\u201344.","journal-title":"Stroke"},{"issue":"1","key":"2913_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000081913","volume":"19","author":"PJ Touboul","year":"2005","unstructured":"Touboul PJ, Vicaut E, Labreuche J, Belliard JP, Cohen S, Kownator S, et al. Design, baseline characteristics and carotid intima-media thickness reproducibility in the PARC study. Cerebrovasc Dis. 2005;19(1):57\u201363.","journal-title":"Cerebrovasc Dis"},{"key":"2913_CR14","doi-asserted-by":"crossref","unstructured":"PJ Touboul, MG Hennerici, S Meairs, H Adams, P Amarenco, N Bornstein, L Csiba M, Desvarieux, S Ebrahim, R. Hernandez Hernandez, M Jaff, S Kownator, T Naqvi, P Prati T, Rundek, M Sitzer, U Schminke, JC Tardif, A Taylor, E Vicaut and KW. Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004\u20132006\u20132011): An Update. Cerebrovasc Dis. 2012;34(4):290\u20136.","DOI":"10.1159\/000343145"},{"issue":"2","key":"2913_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/prp2.131","volume":"3","author":"RJ Keizer","year":"2015","unstructured":"Keizer RJ, Jansen RS, Rosing H, Thijssen B, Beijnen JH, Schellens JHM, et al. Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses. Pharmacol Res Perspect. 2015;3(2):1\u201315.","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"2913_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/1047322X.1990.10389587","volume":"5","author":"RW Hornung","year":"1990","unstructured":"Hornung RW, Reed LD. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg. 1990;5(1):46\u201351.","journal-title":"Appl Occup Environ Hyg"},{"issue":"39","key":"2913_CR17","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","volume":"43","author":"F Kronenberg","year":"2022","unstructured":"Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925\u201346. https:\/\/doi.org\/10.1093\/eurheartj\/ehac361.","journal-title":"Eur Heart J"},{"issue":"1","key":"2913_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-95141-0","volume":"11","author":"P Kumar","year":"2021","unstructured":"Kumar P, Swarnkar P, Misra S, Nath M. Lipoprotein (a) level as a risk factor for stroke and its subtype: a systematic review and meta-analysis. Sci Rep. 2021;11(1):1\u201313.","journal-title":"Sci Rep"},{"issue":"132","key":"2913_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejim.2024.12.002","volume":"1","author":"G Bosco","year":"2025","unstructured":"Bosco G, Di Giacomo BF, Di Marco M, Scilletta S, Miano N, Capuccio S, et al. Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis. Eur J Intern Med. 2025;1(132):118\u201326.","journal-title":"Eur J Intern Med"},{"issue":"3 SUPPL.","key":"2913_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0002-9149(02)03143-0","volume":"91","author":"P Libby","year":"2003","unstructured":"Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol. 2003;91(3 SUPPL.):3\u20136.","journal-title":"Am J Cardiol"},{"issue":"10","key":"2913_CR21","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","volume":"49","author":"C Bergmark","year":"2008","unstructured":"Bergmark C, Dewan A, Orsoni A, Merki E, Miller ER, Shin MJ, et al. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. J Lipid Res. 2008;49(10):2230\u20139.","journal-title":"J Lipid Res"},{"issue":"2","key":"2913_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.coph.2013.02.005","volume":"13","author":"G Leibundgut","year":"2013","unstructured":"Leibundgut G, Witztum JL, Tsimikas S. Oxidation-specific epitopes and immunological responses: translational biotheranostic implications for atherosclerosis. Curr Opin Pharmacol. 2013;13(2):168\u201379.","journal-title":"Curr Opin Pharmacol"},{"issue":"8","key":"2913_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.116.020838","volume":"134","author":"FM Van Der Valk","year":"2016","unstructured":"Van Der Valk FM, Bekkering S, Kroon J, Yeang C, Van Den Bossche J, Van Buul JD, et al. Oxidized phospholipids on Lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans. Circulation. 2016;134(8):611\u201324.","journal-title":"Circulation"},{"issue":"4","key":"2913_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/00041433-200308000-00004","volume":"14","author":"SM Marcovina","year":"2003","unstructured":"Marcovina SM, Koschinsky ML. Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside. Curr Opin Lipidol. 2003;14(4):361\u20136.","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"2913_CR25","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1161\/01.ATV.19.4.990","volume":"19","author":"OT Raitakari","year":"1999","unstructured":"Raitakari OT, Adams MR, Celermajer DS. Effect of Lp(a) on the early functional and structural changes of atherosclerosis. Arterioscler Thromb Vasc Biol. 1999;19(4):990\u20135.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2913_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2006.01.017","volume":"190","author":"MT Grebe","year":"2007","unstructured":"Grebe MT, Schoene E, Schaefer CA, Boedeker RH, Kemkes-Matthes B, Voss R, et al. Elevated lipoprotein(a) does not promote early atherosclerotic changes of the carotid arteries in young, healthy adults. Atherosclerosis. 2007;190(1):194\u20138.","journal-title":"Atherosclerosis"},{"issue":"1","key":"2913_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1161\/CIRCULATIONAHA.122.060667","volume":"147","author":"O Raitakari","year":"2023","unstructured":"Raitakari O, Kartiosuo N, Pahkala K, Hutri-K\u00e4h\u00f6nen N, Bazzano LA, Chen W, et al. Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood. Circulation. 2023;147(1):23\u201331.","journal-title":"Circulation"},{"issue":"1","key":"2913_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000492329","volume":"65","author":"S Kiechl","year":"2019","unstructured":"Kiechl S, Willeit J. In a nutshell: findings from the Bruneck Study. Gerontology. 2019;65(1):9\u201319.","journal-title":"Gerontology"},{"key":"2913_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2021.06.004","volume":"329","author":"DHK van Dam-Nolen","year":"2021","unstructured":"van Dam-Nolen DHK, van Dijk AC, Crombag GAJC, Lucci C, Kooi ME, Hendrikse J, et al. Lipoprotein(a) levels and atherosclerotic plaque characteristics in the carotid artery: the Plaque at RISK (PARISK) study. Atherosclerosis. 2021;329:22\u20139.","journal-title":"Atherosclerosis"},{"issue":"9","key":"2913_CR30","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.amjcard.2014.08.001","volume":"114","author":"XQ Zhao","year":"2014","unstructured":"Zhao XQ, Hatsukami TS, Hippe DS, Sun J, Balu N, Isquith DA, et al. Clinical factors associated with high-risk carotid plaque features as assessed by magnetic resonance imaging in patients with established vascular disease (from the AIM-HIGH study). Am J Cardiol. 2014;114(9):1412\u20139.","journal-title":"Am J Cardiol"},{"issue":"10","key":"2913_CR31","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1161\/ATVBAHA.108.169292","volume":"28","author":"JH Klein","year":"2008","unstructured":"Klein JH, Hegele RA, Hackam DG, Koschinsky ML, Huff MW, Spence JD. Lipoprotein(a) is associated differentially with carotid stenosis, occlusion, and total plaque area. Arterioscler Thromb Vasc Biol. 2008;28(10):1851\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2913_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.atherosclerosis.2010.07.007","volume":"212","author":"BS Kim","year":"2010","unstructured":"Kim BS, Jung HS, Bang OY, Chung CS, Lee KH, Kim GM. Elevated serum lipoprotein(a) as a potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke. Atherosclerosis. 2010;212(2):682\u20138.","journal-title":"Atherosclerosis"},{"key":"2913_CR34","doi-asserted-by":"crossref","unstructured":"Bosco G, Di Giacomo Barbagallo F, Di Marco M, Scilletta S, Miano N, Pistritto C, et al. Translating the effect of dual lipid reduction with PCSK9 inhibitors on a mechanical vascular instrumental biomarker in familial hypercholesterolemia subjects. J Transl Med. 2025;23(1):1371.\u00a0Available from: https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07432-z","DOI":"10.1186\/s12967-025-07432-z"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-02913-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02913-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02913-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:42:28Z","timestamp":1776084148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-02913-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2913"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-02913-6","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As described in the methods section, the BIOSIGNAL (Biomarker Signature of Stroke Aetiology) study (ClinicalTrials.gov NCT02274727) was approved by the University of Zurich Ethics Commission which is part of the Center for Ethics at the University of Zurich, Switzerland. It was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent for publication was obtained from all participants or their welfare guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PJ Touboul ist the CEO of Intelligence in Medical Technologies who provided the M\u2019Ath Software for the IMT measurements. The remaining authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}